Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,358 public trials 356 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One

NCT00530348

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • Barrow Neurological Institute, St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Northwest NeuroSpecialists, PLLC Tucson, Arizona, United States
View all 101 locations
View Trial Details
Completed

Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis

NCT01517282

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Morphosys Investigative Site Berlin, Germany
  • Morphosys Investigative Site Gdansk, Poland
  • Morphosys Investigative Site Poznan, Poland
  • Morhosys Investigative Site Manchester, United Kingdom
View Trial Details
Completed

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

NCT01112657

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Kaohsiung Medical University, Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chang-Gung Memorial Hospital - Kaohsiung Branch Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Completed

Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

NCT01440101

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Chiba, Japan
  • Research Site Fukuoka, Japan
  • Research Site Hiroshima, Japan
  • Research Site Kawagoe, Japan
View all 17 locations
View Trial Details
Completed

Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

NCT00906399

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Ponte Vedra Beach, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Des Moines, Iowa, United States
View all 178 locations
View Trial Details
Completed

Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.

NCT01405872

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Glostrup Municipality, Denmark
  • Research Site Holstebro, Denmark
  • Research Site Næstved, Denmark
  • Research Site Amiens, France
View all 64 locations
View Trial Details

Related conditions